Jun 16, 2026, 09:30 ET4E Therapeutics Acquired by Lilly to Advance Non-Opioid Approach to Chronic Pain
Acquisition combines 4E's innovative MNK inhibitor with Lilly's broad neuroscience capabilities and portfolio AUSTIN, Texas, June 16, 2026 /PRNewswire/ -- 4E Therapeutics, Inc. ("4E"), an...